Article: Derma Sciences Announces $6 Million Agreement.

3-year deal with large Canadian retail pharmacy chain ties exclusivity on MEDIHONEY(TM) Antimicrobial dressings with extended wound care line

PRINCETON, N.J., May 22 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (BULLETIN BOARD: DSCI) , a provider of advanced wound-care products, announced today that it has reached an agreement in principle with a major Canadian retail pharmacy chain, and expects a contract to be executed by both parties in the near future. The terms call for minimum purchases of $2 million each year for three years, totaling at least $6 million. The $2 million per year will be comprised of a mix of MEDIHONEY(TM) antimicrobial dressings, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!